Skip to content
Back to resident companies

Concerto Biosciences

Investment areas

  • Biotech / Life Sciences
  • Applied AI & ML
Founders & Leadership
Cheri Ackerman
Jared Kehe
Bernardo Cervantes
Headquarters
Cambridge, MA

Tap into the microbial world.

The Tough Tech problem we are solving

Microbe-based products are an inevitable future in medicine, food, and consumer goods. The major challenge in creating these products—and capturing their economic potential—is intelligence: accurately predicting the right microbes to ensure a product’s optimal effectiveness. Concerto uniquely owns extensive datasets, generated by our proprietary coculture screening device, that fuel accurate AI-powered predictions, positioning us as the leader in unlocking this new scientific and economic frontier.

About our solution

Concerto is building the intelligence platform to map the relationships among microbes.

This platform begins with kChip, a high-throughput coculture device that screens millions of microbial combinations to generate the world’s largest dataset on how microbes interact, compete, and cooperate under diverse conditions. These data—particularly when used to train AI models—allow for precise, predictive insights into microbial behavior and function.

Through kChip’s vast dataset and kChip-powered AI models, we identify microbial consortia with specific, valuable traits—such as pathogen suppression or metabolite production—that can be applied across industries, including therapeutics, consumer goods, agriculture, and food. By transforming complex microbial ecosystems into actionable insights, Concerto’s intelligence platform accelerates the development of natural, sustainable solutions, creating high-value products that address critical needs in health and beyond.